Lodi

Researchers are conducting a study to continuously evaluate the quality of healthcare provided in semi-intensive care units. The goal is to develop indicators that measure healthcare quality based on data collected from patients in these units and the structural characteristics of the hospitals. This evaluation aims to identify areas of care that need improvement for different types of patients. The study will collect and analyze data over a period of five years. Each year, a report will be produced to show the results and quality levels of care in each semi-intensive care unit. This ongoing monitoring will help assess the care provided and guide improvements. Participants in the study are patients hospitalized in semi-intensive care units. Data related to patient care and hospital structures will be gathered and used to create quality indicators. The outcomes measured include healthcare quality for various patient risk groups, with continuous evaluation from January 2021 through December 2025. Annual reports will track the progress and effectiveness of care in these units.

Researchers are studying the usefulness of bronchoscopy in patients who cough up blood (haemoptysis) but have negative or non-diagnostic chest CT scans. The study aims to determine how often bronchoscopy can provide a diagnosis when CT scans do not. It also seeks to identify hidden cancers, the bleeding source, and clinical characteristics of these patients. This is a prospective, observational, multicenter study involving respiratory units across Europe. Participants will undergo bronchoscopy, which may include biopsies and fluid collections from the airways to help identify causes of haemoptysis. Before bronchoscopy, patients will have pulmonary exams and blood tests. Chest CT scans with intravenous contrast must be done within 72 hours of bleeding episodes, and bronchoscopy will be performed within two weeks of the CT scan. The study plans to enroll at least 150 adults and will last two years. During the study, participants will be followed for one year with phone interviews at 1, 3, 6, and 12 months. If bleeding recurs, clinical evaluations and further diagnostic work-ups may be done. Researchers will measure the proportion of patients in whom bronchoscopy provides a diagnosis, detects unseen cancers, identifies bleeding sources, causes treatment changes, and assess symptom recurrence and mortality over one year.